id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-D-0150-0021,FDA,FDA-2008-D-0150,Guidance for Industry Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims,Other,Guidance,2022-12-15T05:00:00Z,2022,12,2022-12-15T05:00:00Z,,2024-11-12T23:16:26Z,,1,0,090000648430862c